ICD code G62.9 – Unspecified polyneuropathy

Key takeaways

G62.9 codes polyneuropathy the provider has confirmed but whose cause is not documented or is still under investigation.

G62.9 has no Excludes notes of its own, but a documented cause such as diabetes (E11.42), a drug (G62.0) or alcohol (G62.1) takes priority.

Documentation must confirm polyneuropathy, not just symptoms, and state that the etiology is unknown or under active investigation.

Pabau sends claims through Claim.MD and posts the payer’s remittance back to the same patient record as the clinical note.

ICD-10 Code G62.9: Quick reference for coders and billers

ICD-10 Code G62.9 is the billable ICD-10-CM code for polyneuropathy, unspecified. It covers confirmed damage to multiple peripheral nerves when the record names no cause, or the cause is still being worked up. Any documented cause, such as diabetes, a drug or alcohol, moves the claim to a more specific code.

Every claim in the medical billing process starts with the same check. The code has to be billable, correctly categorized, and valid for the date of service. The table below holds those facts for G62.9.

The CDC/NCHS ICD-10-CM web tool is the authoritative source for verifying code validity by fiscal year. Confirm G62.9 is active for the date of service before submitting.

What G62.9 covers: Included conditions and clinical scope

G62.9 applies when polyneuropathy is the confirmed diagnosis and no specific etiology has been identified or documented. Polyneuropathy means damage to several peripheral nerves at once. It typically presents as symmetrical distal weakness, sensory loss, or autonomic dysfunction.

The “unspecified” label is not a documentation failure by default. It is clinically appropriate in these situations:

• Idiopathic polyneuropathy: A cause has been sought and not found after a reasonable workup.
• Cryptogenic polyneuropathy: The neurology term for a neuropathy with no identifiable cause after nerve conduction studies, laboratory screening, and a metabolic workup.
• Polyneuropathy NOS (not otherwise specified): The provider documents polyneuropathy without a type, and no specific cause appears anywhere in the medical record.
• Active workup in progress: The etiology is under investigation at the time of coding. G62.9 may be used in the meantime, as the section on coding during workup explains.

Small fiber neuropathy raises a common coding question. When skin punch biopsy or quantitative sensory testing confirms it, it typically falls under G62.9 if no systemic cause is documented. Some practices also consider G64 (other disorders of the peripheral nervous system), so confirm with the treating neurologist before assigning either code.

Codes that take priority over G62.9

G62.9 carries no Excludes1 or Excludes2 notes of its own in the ICD-10-CM Tabular List. Its only note is the inclusion term “Neuropathy NOS.” What keeps it off a claim is specificity. When the record names a cause, the code for that cause is the accurate one, and an unspecified code risks a CO-11 denial.

The formal Excludes1 note for diabetic and other disease-related polyneuropathy sits under a different code, G63 (polyneuropathy in diseases classified elsewhere). The table below lists the codes to use when the cause is documented.

Diabetes is the cause that matters most in practice. ICD-10-CM’s “with” convention (Section I.A.15 of the Official Guidelines) presumes a link between diabetes and polyneuropathy.

When both appear in the record, code E11.42 or E10.42 even if the note never says “diabetic,” unless the provider states the two are unrelated.

The CMS ICD-10-CM coding guidelines carry the current version of that convention.

Adjacent G62 sibling codes: When to use each

G62.9 is the residual code within the G62 category. Before assigning it, confirm that no sibling code matches the documented condition more precisely.

The G62.9 versus G60.9 distinction trips up many coders. G60.9 covers hereditary and idiopathic neuropathies in category G60, while G62.9 belongs to G62. When the provider documents a suspected hereditary pattern or a family history of neuropathy, G60.9 is the better fit, even without a confirmed genetic diagnosis.

Put together, the choice comes down to two questions a coder answers in order, as the chart below shows.

Documentation requirements to support ICD-10 Code G62.9

G62.9 is a legitimate code, but it needs solid documentation behind it. Without the right elements in the clinical note, it will not survive a payer audit. It may also fail to support medical necessity for related procedures like nerve conduction studies.

Submitting a clean claim for neurology services means the supporting diagnosis documentation is in place before the claim leaves the practice. These are the elements to check:

1. Confirmed polyneuropathy diagnosis (not just symptoms): The provider note must state “polyneuropathy” explicitly, not only “numbness,” “tingling,” or “peripheral neuropathy symptoms.” Symptom codes (R20.-) cannot substitute for a confirmed diagnosis code.
2. Completed or rationale-supported workup: Document nerve conduction study (NCS) or electromyography (EMG) results, or the clinical rationale if electrodiagnostic testing was deferred. Most payers want evidence of a diagnostic workup before G62.9 supports a related procedure.
3. Etiology statement: The note must state that the cause is unknown, under investigation, or not identified after workup. Language such as “etiology undetermined,” “cryptogenic polyneuropathy,” or “neuropathy of unknown origin” satisfies this requirement.
4. No more specific documented cause: Review the entire medical record, not only the encounter note. Diabetes anywhere in the chart points to E11.42 or E10.42 under the “with” convention. A causative medication or alcohol use calls for a provider query before G62.9 is assigned.

When the clinical note documents only “neuropathy” without a type or distribution, a clinical documentation improvement (CDI) query is appropriate. Ask the provider two things. Is this mononeuropathy, polyneuropathy, or radiculopathy? And is the etiology known? The answers prevent both undercoding and miscoding.

Payer coverage and Medicare LCD requirements for G62.9

G62.9 most often appears as the supporting diagnosis for nerve conduction studies (NCS/EMG). Medicare Administrative Contractors (MACs) publish Local Coverage Determinations (LCDs) that govern when electrodiagnostic testing is covered.

G62.9 is listed as a covered supporting diagnosis in several active MAC LCDs, including those maintained by Novitas Solutions and CGS Administrators.

Practices using electronic claims via Claim.MD can run real-time eligibility checks before the encounter. That confirms whether a patient’s plan covers neurology services under G62.9 before the visit happens.

Key coverage rules coders must know:

• G62.9 alone may not satisfy medical necessity for NCS if symptom severity or failed conservative treatment is not also documented. Medicare LCDs for electrodiagnostic testing typically require clinical indicators such as progressive weakness, sensory deficit, or autonomic dysfunction.
• Prior authorization rules for neurology referrals coded G62.9 vary by commercial payer and plan. Some plans require a specified etiology before authorizing a specialist referral, while others accept G62.9 for an initial evaluation. Check each payer separately.
• Medicare Part B covers electrodiagnostic testing when G62.9 is listed as a covered indication in the applicable MAC LCD. LCDs are updated periodically, so verify the current LCD number and covered diagnoses on the MAC’s website before submitting.

Coding G62.9 when etiology is under investigation

Section I.B.4 of the ICD-10-CM Official Guidelines for Coding and Reporting covers signs and symptoms. Symptom codes are acceptable only until the provider establishes a related definitive diagnosis.

So once a provider has confirmed polyneuropathy but not its cause, G62.9 is the correct code. A symptom code for tingling or weakness no longer fits.

The workflow below applies to outpatient and physician office encounters, which follow Section IV of the guidelines. Inpatient coding follows Section II instead. Maintaining medical billing compliance during an active workup depends on applying these steps the same way every time.

1. Encounter during initial workup: Code G62.9. The provider has confirmed polyneuropathy, and the etiology is not yet documented. Do not code symptoms instead of the confirmed diagnosis.
2. Subsequent encounter, etiology still unknown: Continue coding G62.9, and make sure the note says “etiology under investigation” or similar. That wording protects the code if an auditor later argues the unspecified designation was a documentation deficiency.
3. Follow-up encounter, specific etiology confirmed: Stop using G62.9. Assign the specific code, such as G62.0 for a confirmed causative drug or E11.42 for diabetic polyneuropathy. Do not carry G62.9 forward once a cause is established.
4. Suspected but unconfirmed etiology: In an outpatient setting, Section IV.H says not to code a diagnosis documented as “probable” or “suspected.” Code G62.9 and leave the suspected cause off the claim. Inpatient rules differ, because Section II.H lets coders report an uncertain diagnosis documented at discharge.

Common claim denial reasons for G62.9 and how to avoid them

Unspecified codes attract scrutiny from payers, and G62.9 is no exception. Denial management workflows that tag G62.9 claims for pre-submission review catch the most common rejection reasons. The table below pairs each scenario with its claim adjustment reason code and the fix.

Reviewing the full chart for diabetes, active medications, and alcohol history before assigning G62.9 prevents the most frequent denial scenario. The check takes a couple of minutes per encounter. It saves the denial, appeal, and rework cycle that follows a CO-11.

How Pabau keeps G62.9 claims tied to the chart

Most G62.9 denials start before the claim is built. The coder works from the encounter note and never sees the diabetes on the problem list or the chemotherapy in the medication history.

Pabau’s claims management software builds the claim from the patient record that already holds the treatment notes and history. A coder checking for a documented cause reads one chart. US claims go out through the Claim.MD clearinghouse as CMS-1500 or 837P claims, with eligibility checks run before the visit.

Electronic remittance advice comes back against the same record, so a CO-11 or CO-50 adjustment sits next to the note that caused it. Prior authorization codes for nerve conduction studies are tracked on the patient’s case, with a warning when one is missing.

Send G62.9 claims that hold up to review

Pabau builds each claim from the patient record and sends it through Claim.MD, with eligibility checks and remittances in the same place. See how it handles neurology billing.

Book a demo

Conclusion

G62.9 is a fair code with a narrow job. It belongs on a claim only after someone has read the whole chart and found no cause, and the note says so in plain words.

The habit that pays is simple. Check for diabetes, medications and alcohol before choosing the code, and replace G62.9 the moment the workup names a cause. Skip either step and the code that looked safe becomes the denial. Book a demo to see how Pabau keeps the chart and the claim in one place for neurology billing.

Continue your research

Need to understand how claims move from submission to payment? Claim.MD clearinghouse overview explains how electronic claims are validated, routed, and tracked through the US clearinghouse system.

Seeing recurring CO-11 or CO-50 denials across your neurology claims? Denial codes in medical billing breaks down the most common claim adjustment reason codes and the corrective actions for each.

Want to see where diagnosis coding sits in the revenue cycle? Revenue cycle management guide covers how diagnosis coding fits into the broader RCM workflow from eligibility to payment posting.

Frequently asked questions about ICD-10 Code G62.9